Condition (MeSH)
Neurodermatitis
ClinicalTrials.gov lists 22 trials for Neurodermatitis or a narrower condition beneath it. Sanofi has the most among industry and government lead sponsors, with 4.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
22 of the 22 trials are tagged with Neurodermatitis itself; the rest are tagged with a narrower condition beneath it.
When did Neurodermatitis trials start? (13)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 1
- Phase 2
- Phase 3
- Phase 4
- Not applicable
Top of scale: 4
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2026 (partial year) | 2 |
| 2025 | 1 |
| 2024 | 4 |
| 2023 | 1 |
| 2022 | 2 |
| 2020 | 3 |
| 2019 | 2 |
| 2018 | 2 |
| 2013 | 1 |
| 2012 | 1 |
Showing 10 of 13 earlier years.
No forecast is made for this condition: it averages 2.0 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: 1 trial still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Neurodermatitis trials in? (5)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 1 | 4 |
| Phase 2 | 2 |
| Phase 3 | 8 |
| Phase 4 | 2 |
| Not applicable | 6 |
How many Neurodermatitis trials are recruiting? (4)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Not yet recruiting | 1 |
| Recruiting | 1 |
| Completed | 18 |
| Unknown status | 2 |
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Neurodermatitis trials? (9)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| Sanofi | 4 |
| Galderma R&D | 2 |
| Prime Gene Therapeutics Co., Ltd. | 2 |
| Cook County Health | 1 |
| Dove Medical Press Ltd | 1 |
Showing 5 of 9 sponsors.
Which drugs are being tested for Neurodermatitis? (1)
Shown in this order: most trials first. One row per drug, matched to a single molecule under all its names, ranked by number of trials.
| Drug | Trials |
|---|---|
| Nemolizumab | 2 |
Interventions as named in the registry (14)
Shown in this order: most trials first.
| Drug | Trials |
|---|---|
| Dupilumab/Dupixent | 2 |
| Moisturizers | 2 |
| Low to medium potent topical corticosteroids | 2 |
| Topical calcineurin inhibitors | 2 |
| Dupilumab SAR231893 | 2 |
Showing 5 of 14 interventions.
These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.
Which serious adverse events do Neurodermatitis trials report? (10)
Shown in this order: most subjects affected first. Subjects affected summed across trials, a cross-trial signal, not a rate.
| Adverse event | Subjects affected | Trials |
|---|---|---|
| Neurodermatitis | 6 | 2 |
| Acute Myocardial Infarction | 2 | 1 |
| Cellulitis | 2 | 1 |
| Osteoarthritis | 2 | 2 |
| Pemphigoid | 2 | 2 |
Showing 5 of 10 adverse events.
Which publications cover Neurodermatitis? (8)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Botulinum toxin type A injection in the treatment of lichen simplex: an open pilot study. | Journal of the American Academy of Dermatology | 2002 | Yes |
| Vulvar dermatoses: lichen sclerosus, lichen planus, and vulval dermatitis/lichen simplex chronicus. | Seminars in cutaneous medicine and surgery | 1998 | Yes |
| Vulvovaginal Issues in Mature Women. | Mayo Clinic proceedings | 2017 | No |
| Recognition and management of vulvar dermatologic conditions: lichen sclerosus, lichen planus, and lichen simplex chronicus. | Journal of midwifery & women's health | 2012 | No |
| Characteristic dermoscopic features of primary cutaneous amyloidosis: a study of 35 cases. | The British journal of dermatology | 2012 | No |
Showing 5 of 8 publications.
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: prevalence, rare-disease identity, and sub-conditions in mesh.